Charlotta Lind

Charlotta Lind is an accomplished professional in the pharmaceutical and biotechnology sectors, currently serving as the Regional Business Director for the Nordic region at Grünenthal Group since October 2022, where Charlotta leads a cross-functional team to enhance pain management solutions. Prior experience at Galderma included roles as Nordic Marketing Manager for Prescription, where Charlotta successfully drove product growth in multiple therapeutic areas, and Business Unit Head Stand-in, overseeing marketing and sales teams during crucial launches. Prior to that, Charlotta held various positions at AstraZeneca, including Regional Product Manager and Sales Representative. Charlotta holds a Master of Science in Biology from Uppsala University and The Ohio State University.